Medical oncology workload, workforce census, and needs in Spain: two nationwide studies by the Spanish Society of medical oncology

por Fernandez Montes, Ana, Elez, Elena, de la Haba-Rodriguez, Juan, Paez, David, Mendez-Vidal, Maria Jose, Felip, Enriqueta, Rodriguez-Lescure, Alvaro
Publicado 2023

Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma

por Méndez-Vidal, María José, Molina, Áurea, Anido, Urbano, Chirivella, Isabel, Etxaniz, Olatz, Fernández-Parra, Eva, Guix, Marta, Hernández, Carolina, Lambea, Julio, Montesa, Álvaro, Pinto, Álvaro, Ros, Silverio, Gallardo, Enrique
Publicado 2018

Expert recommendations on the management of patients with metastatic castration-resistant prostate cancer who progress after CHAARTED or LATITUDE

por Puente, Javier, Anido, Urbano, Climent, Miguel Ángel, Gonzalez-Billalabeitia, Enrique, Lainez, Nuria, Lambea, Julio, Maroto, José Pablo, Mendez-Vidal, Maria Jose, Montesa, Álvaro, Rodriguez, Angel, Zambrana, Curro, González-del-Alba, Aránzazu
Publicado 2020

SEOM SOGUG clinical guideline for treatment of kidney cancer (2022)

por Méndez-Vidal, María José, Lázaro Quintela, Martin, Lainez-Milagro, Nuria, Perez-Valderrama, Begoña, Suárez Rodriguez, Cristina, Arranz Arija, José Ángel, Peláez Fernández, Ignacio, Gallardo Díaz, Enrique, Lambea Sorrosal, Julio, González-del-Alba, Aránzazu
Publicado 2023

Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer:...

por Puente, Javier, González-del-Alba, Aranzazu, Sala-Gonzalez, Núria, Méndez-Vidal, María José, Pinto, Alvaro, Rodríguez, Ángel, Cuevas Sanz, José Miguel, Muñoz del Toro, Jacobo Rodrigo, Useros Rodríguez, Eduardo, García García-Porrero, Ángela, Vázquez, Sergio
Publicado 2019

Re‐treatment with radium‐223: 2‐year follow‐up from an international, open‐label, phase 1/2 study in patients with castration‐resistant prostate cancer and bone metastases...

por Sartor, Oliver, Heinrich, Daniel, Mariados, Neil, Méndez Vidal, Maria José, Keizman, Daniel, Thellenberg Karlsson, Camilla, Peer, Avivit, Procopio, Giuseppe, Frank, Stephen J., Pulkkanen, Kalevi, Rosenbaum, Eli, Severi, Stefano, Trigo, José, Trandafir, Lucia, Wagner, Volker, Li, Rui, Nordquist, Luke T.
Publicado 2019

Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study

por Juan Fita, María José, Anido Herranz, Urbano, Mendez-Vidal, María José, Gironés-Sarrió, Regina, Muñoz-Langa, José, Sepúlveda-Sánchez, Juan, Mellado, Begoña, Alvarez-Fernandez, Carlos, Heras López, Lucía, López-Guerrero, José Antonio, García-Casado, Zaida, Calatrava, Ana, Ángel Climent, Miguel
Publicado 2023

Clinical Utility of Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Diagnostic Tool and Potential Therapeutic Target in Prostate Cancer

por Jiménez-Vacas, Juan M., Gómez-Gómez, Enrique, Montero-Hidalgo, Antonio J., Herrero-Aguayo, Vicente, L-López, Fernando, Sánchez-Sánchez, Rafael, Guler, Ipek, Blanca, Ana, Méndez-Vidal, María José, Carrasco, Julia, Lopez-Miranda, José, Requena-Tapia, María J., Castaño, Justo P., Gahete, Manuel D., Luque, Raúl M.
Publicado 2019

Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms

por Grünwald, Viktor, Powles, Thomas, Eto, Masatoshi, Kopyltsov, Evgeny, Rha, Sun Young, Porta, Camillo, Motzer, Robert, Hutson, Thomas E., Méndez-Vidal, María José, Hong, Sung-Hoo, Winquist, Eric, Goh, Jeffrey C., Maroto, Pablo, Buchler, Tomas, Takagi, Toshio, Burgents, Joseph E., Perini, Rodolfo, He, Cixin, Okpara, Chinyere E., McKenzie, Jodi, Choueiri, Toni K.
Publicado 2023

Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma

por Puente, Javier, Laínez, Nuria, Dueñas, Marta, Méndez-Vidal, María José, Esteban, Emilio, Castellano, Daniel, Martinez-Fernández, Mónica, Basterretxea, Laura, Juan-Fita, María José, Antón, Luis, León, Luis, Lambea, Julio, Pérez-Valderrama, Begoña, Vázquez, Sergio, Suarez, Cristina, del Muro, Xavier Garcia, Gallardo, Enrique, Maroto, José Pablo, Samaniego, M Luz, Suárez-Paniagua, Beatriz, Sanz, Julián, Paramio, Jesús M.
Publicado 2017

Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib

por Cebrián, Arancha, Gómez del Pulgar, Teresa, Méndez-Vidal, María José, Gonzálvez, María Luisa, Lainez, Nuria, Castellano, Daniel, García-Carbonero, Iciar, Esteban, Emilio, Sáez, Maria Isabel, Villatoro, Rosa, Suárez, Cristina, Carrato, Alfredo, Munárriz-Ferrándiz, Javier, Basterrechea, Laura, García-Alonso, Mirta, González-Larriba, José Luis, Perez-Valderrama, Begoña, Cruz-Jurado, Josefina, González del Alba, Aránzazu, Moreno, Fernando, Reynés, Gaspar, Rodríguez-Remírez, María, Boni, Valentina, Mahillo-Fernández, Ignacio, Martin, Yolanda, Viqueira, Andrea, García-Foncillas, Jesús
Publicado 2017

Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study

por Lainez, Nuria, García-Donas, Jesús, Esteban, Emilio, Puente, Javier, Sáez, M. Isabel, Gallardo, Enrique, Pinto-Marín, Álvaro, Vázquez-Estévez, Sergio, León, Luis, García-Carbonero, Icíar, Suárez-Rodríguez, Cristina, Molins, Carmen, Climent-Duran, Miguel A., Lázaro-Quintela, Martín, González del Alba, Aranzazu, Méndez-Vidal, María José, Chirivella, Isabel, Afonso, Francisco J., López-Brea, Marta, Sala-González, Nuria, Domenech, Montserrat, Basterretxea, Laura, Santander-Lobera, Carmen, Gil-Arnáiz, Irene, Fernández, Ovidio, Caballero-Díaz, Cristina, Mellado, Begoña, Marrupe, David, García-Sánchez, José, Sánchez-Escribano, Ricardo, Fernández Parra, Eva, Villa Guzmán, José C., Martínez-Ortega, Esther, Belén González, María, Morán, Marina, Suarez-Paniagua, Beatriz, Lecumberri, María J., Castellano, Daniel
Publicado 2016